IDEQUI
Business purpose.
Développement de diagnostics pour les maladies des équidés
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- 3 to 5 employees
- Created
- 10 Feb 2023
- Share capital
- 1,000,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 2
Directors
- PHILIPPE MARIE RAYMOND POURQUIER 65 years old, 12/1960 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- POURQUIER 92 via PHILIPPE MARIE RAYMOND POURQUIER
- INNOVATIVE DIAGNOSTICS via PHILIPPE MARIE RAYMOND POURQUIER
- KANI via PHILIPPE MARIE RAYMOND POURQUIER
- SCI POURQUIER via PHILIPPE MARIE RAYMOND POURQUIER
- EFATA 2015 via PHILIPPE MARIE RAYMOND POURQUIER
- INNOVATIVE DIAGNOSTIC via PHILIPPE MARIE RAYMOND POURQUIER
- PROGASTRIN MANUFACTURING via PHILIPPE MARIE RAYMOND POURQUIER
- TALITHA 2021 via PHILIPPE MARIE RAYMOND POURQUIER
- STELLA MARIS via PHILIPPE MARIE RAYMOND POURQUIER
- BIODENA CARE GROUP via PHILIPPE MARIE RAYMOND POURQUIER
- AFYIA DIAGNOSTICS via PHILIPPE MARIE RAYMOND POURQUIER
Other companies at the same address
2 other company head offices are registered at this address.
Establishments
-
94895998600019 34790 GRABELS
Financial strength
Financial score
25 / 100 E
Confidence: medium · computed on the financial year ended 31 Dec 2025
- Equity to assets (14.3 %)
- 7.6 out of 30
- EBITDA margin (-428.4 %)
- 0.0 out of 25
- Liquidity (122.9 %)
- 4.6 out of 20
- Debt (40.6 %)
- 10.1 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
88 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (3.7 years)
- 7.5 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 72,210 € | — | -473,358 € | -329,519 € |
| 31 Dec 2023 | 0 € | first year on record | -323,658 € | -195,395 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale des industries chimiques et connexes du 30 décembre 1952. Étendue par arrêté du 13 novembre 1956 JONC 12 décembre 1956
IDCC 0044 · in force, extended · 1 establishment · declared in July 2026
Legal notices
-
Filing of accounts 28 Jul 2026
- Court :
- Greffe du Tribunal de Commerce de caen
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260141, annonce n 2161 · Proof of publication (PDF)
-
Filing of accounts 5 Aug 2025
- Court :
- Greffe du Tribunal de Commerce de caen
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250148, annonce n 2012 · Proof of publication (PDF)
-
Filing of accounts 28 Jan 2025
- Court :
- Greffe du Tribunal de Commerce de caen
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20250019, annonce n 734 · Proof of publication (PDF)
-
Registration 23 May 2023
- Court :
- Greffe du Tribunal de Commerce de Caen
- Filing :
- immatriculation suite à transfert de son siège social hors ressort.
BODACC A n 20230098, annonce n 402 · Proof of publication (PDF)
-
Incorporation 19 Feb 2023
- Court :
- Greffe du Tribunal de Commerce de Montpellier
BODACC A n 20230035, annonce n 543 · Proof of publication (PDF)
Filings and accounts
- Formality 18 Nov 2025
- Formality 18 May 2023
Change history
- employee_range 01 → 02 4 Nov 2026
- employee_range 01 → 02 3 Nov 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital (empty) → 1000000.00 2 Oct 2026
Frequently asked questions about IDEQUI
- What is the SIREN number of IDEQUI?
- The SIREN number of IDEQUI is 948959986. Its intra-community VAT number is FR04948959986.
- Where is the head office of IDEQUI?
- Head office address: 3 RUE NELSON MANDELA, 14280 SAINT-CONTEST.
- When was IDEQUI founded?
- IDEQUI was founded on 10 Feb 2023.
- What does IDEQUI do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs IDEQUI?
- The officer listed in the register is PHILIPPE MARIE RAYMOND POURQUIER (President de SAS).
- What is the revenue of IDEQUI?
- The latest published revenue is 72,210 €, for the 2025 financial year.
- How many employees does IDEQUI have?
- The declared headcount is 3 to 5 employees. Insee data for 2024.
- Is IDEQUI subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.